secwatch.observer — SEC 8-K summary
======================================

Issuer:     SRx Health Solutions, Inc. (SRXH)
CIK:        0001471727
Form:       8-K
Filed at:   2025-04-30T23:59:59+00:00
Accession:  0001641172-25-007917
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.90
Item codes: 2.01, 5.01, 5.02, 5.03, 8.01, 9.01, 3.02
LLM model:  deepseek-v4-flash:cloud@v2

SRx Health completes reverse merger with Better Choice; rename, new board, $8.8M PIPE
--------------------------------------------------------------------------------

- Former SRx Health stockholders own ~84% of combined entity; Better Choice holders retain ~16% (5.4M shares).
- $8.8M private placement to single investor at $2.18/share: 4.0M shares + pre-funded warrants.
- New board: Adesh Vora (Exec. Chairman), Simon Conway, David White; CEO Kent Cunningham remains.
- SRx Health operates 20 specialty pharmacies, 34 infusion clinics across Canada; FY2023 rev CAD$161M.
- Halo pet business 17% dividend distributed to Predecessor stockholders on April 23, 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1471727/000164117225007917/0001641172-25-007917-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1471727/000164117225007917/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-007917

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer